Brainsway was Featured in the Atlantic

Transcranial Magnetic Stimulation has been consistently growing since 2008 when it was first FDA approved for treatment of depression in the United States. Insurance companies are easing the requirements coverage which will increase the demand.

Deep TMS may be an option for treating your migraines. Here we will discuss the symptoms of migraines and review the data about TMS as a treatment for Migraines

Stanford has done a pivotal study of accelerated TMS treatment for depression using multiple Intermittent Theta Burst Treatments over a five day period, called Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT for short). Read more below.

Brainsway Deep TMS has been cleared by the FDA for the treatment of comorbid anxiety symptoms in adults with Depression. Reducing anxiety symptoms greatly improves a person's quality of life and helps lessen the burden of depression.

The Brainsway Deep TMS device has been FDA cleared for a 3-minute treatment for Depression. The Theta Burst 3 minute treatment was shown to be as effective as the current 19-minute treatment protocol. This offers more convenient treatment options.

Brainsway Deep TMS received FDA Clearance for treating smoking addiction in 2020. With only a few treatment options available to help people quit smoking, it is great to have another safe effective option available.